These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention. Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004 [TBL] [Abstract][Full Text] [Related]
10. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. Guéniau C; Oberlander C J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533 [TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human lipocortin I on brain oedema in a rat glioma model. Chang CC; Shinonaga M; Kuwabara T; Mima T; Shigeno T Acta Neurochir Suppl (Wien); 1990; 51():145-7. PubMed ID: 2151008 [TBL] [Abstract][Full Text] [Related]
12. Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers. Bellissant E; Denolle T; Sinnassamy P; Bichet DG; Giudicelli JF; Lecoz F; Gandon JM; Allain H J Pharmacol Exp Ther; 1996 Jul; 278(1):232-42. PubMed ID: 8764356 [TBL] [Abstract][Full Text] [Related]
13. [Effect of arginine vasopressin (AVP) inhibitor in the inhibition of the peritumoral edema]. Hamada H; Takahashi H; Teramoto A; Yoshii T No To Shinkei; 1997 Nov; 49(11):1001-6. PubMed ID: 9396031 [TBL] [Abstract][Full Text] [Related]
14. Oxygen free radicals in the genesis of peritumoural brain oedema in experimental malignant brain tumours. Ikeda Y; Long DM Acta Neurochir Suppl (Wien); 1990; 51():142-4. PubMed ID: 1965270 [TBL] [Abstract][Full Text] [Related]
15. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019 [TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter amines in brain edema of a rat glioma model. Chang CC Neurol Med Chir (Tokyo); 1989 Mar; 29(3):187-91. PubMed ID: 2477722 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs. Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301 [TBL] [Abstract][Full Text] [Related]
18. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Acri JB; Thompson AC; Shippenberg T Synapse; 2001 Mar; 39(4):343-50. PubMed ID: 11169785 [TBL] [Abstract][Full Text] [Related]
20. Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density. D'Addario C; Di Benedetto M; Izenwasser S; Candeletti S; Romualdi P J Mol Neurosci; 2004; 24(2):307-14. PubMed ID: 15456944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]